Error: Could not add to watchlist. X
+ Watchlist

Rydex Series - Biotechnology Fund

RYBOX:US
NASDAQ GM
68.06
USD
0.67
0.99%
As of 9:29 AM EDT 5/27/2016
Fund Type
Open-End Fund
52Wk Range
59.13 - 99.95
1 Yr Return
-25.98%
YTD Return
-17.23%
Previous Close
67.39
52Wk Range
59.13 - 99.95
1 Yr Return
-26.29%
YTD Return
-17.23%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
U.S.
NAV (on 05/27/2016)
68.06
Total Assets (m USD) (on 05/27/2016)
362.332
Inception Date
09/01/2004
Last Dividend (on 11/17/2015)
1.276
Dividend Indicated Gross Yield
-
Fund Managers
MICHAEL PAUL BYRUM / RYAN A HARDER
Front Load Fee
4.75%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
0.25%
Current Mgmt Fee
0.85%
Expense Ratio
1.58%

Top Fund Holdings

Name Position Value % of Fund
144.90 k 22.94 m 5.82
248.50 k 21.92 m 5.57
344.30 k 21.00 m 5.33
182.11 k 18.83 m 4.78
60.38 k 16.60 m 4.22
34.19 k 12.88 m 3.27
86.57 k 12.06 m 3.06
268.10 k 11.25 m 2.86
114.77 k 9.68 m 2.46
211.91 k 8.84 m 2.24
Profile
Rydex Series - Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests its assets in companies that are involved in the biotechnology industry, including companies involved in research and development, genetic or other biological engineering, and in the design, manufacture, or sale of related biotechnology products.
Address
Rydex Funds
9601 Blackwell Road
Suite 500
Rockville, MD 20850
Phone
1-301-296-5100